¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"phase III trial"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
phase II trial
phase I trial
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
factor III
Á¦3ÀÎÀÚ
clinical trial
ÀÓ»ó½ÃÇè
community trial
Áö¿ª»çȸ½ÃÇè
drug trial
¾à¹°½ÃÇè
open-label trial
°³¹æÇ¥Áö½ÃÇè
randomized controlled trial
¹«ÀÛÀ§´ëÁ¶½ÃÇè
randomized trial
¹«ÀÛÀ§½ÃÇè
acceleration phase
ÃËÁø±â, °¡¼Ó±â
active phase
Ȱ¼º±â
acute phase reactant
±Þ¼º±â¹ÝÀÀ¹°Áú
acute phase reaction
±Þ¼º±â¹ÝÀÀ
acute phase serum
±Þ¼º±âÇ÷û
advanced sleep phase syndrome
ÀüÁø¼ö¸éÀ§»óÁõÈıº
anal-sadistic phase
Ç×¹®°¡Çбâ
bulk phase model
µ¢¾î¸®À§»ó¸ðÇü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
trial
½ÃÇè
clinical trial
ÀÓ»ó½ÃÇè
randomized trial
¹«ÀÛÀ§½ÃÇè
therapeutic trial
½ÃÇèÀûÄ¡·á, Ä¡·á½Ãµµ
luteal phase endometrial biopsy
Ȳü±âÀڱ󻸷»ý°Ë
phase contrast
À§»ó´ëÁ¶
luteal phase defect
Ȳü±â°á¼Õ
phase difference
À§»óÂ÷
phase-contrast microscope
À§»óÂ÷Çö¹Ì°æ
phase
»ó, ±â, À§»ó
acceleration phase
ÃËÁø±â, °¡¼Ó±â
active phase
Ȱ¼º±â
latent phase
ÀáÀç±â , Àẹ±â
plateau phase
ÆíÆò±â, °íÁ¶±â
relaxation phase
À̿ϱâ, À̿ϻó
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
clinical trial
ÀÓ»ó½ÃÇè
community trial
Áö¿ª»çȸ½ÃÇè
trial frame
°Ë»ç¿ë¾È°æÅ×
trial lens
°Ë¾È·»Áî
trial-and-error learning
½ÃÇàÂø¿ÀÇнÀ
open-label trial
°³¹æÇ¥Áö½ÃÇè
randomized trial
¹«ÀÛÀ§½ÃÇè
randomized controlled trial
¹«ÀÛÀ§´ëÁ¶½ÃÇè
trial
½ÃÇè
therapeutic trial
½ÃÇèÀûÄ¡·á
3D phase contrast angiography
»ïÂ÷¿øÀ§»ó´ëÁ¶Ç÷°üÁ¶¿µ¼ú
acceleration phase
ÃËÁø±â, °¡¼Ó±â
acute phase reactant
±Þ¼º±â¹ÝÀÀ¹°Áú
acute phase reaction
±Þ¼º±â¹ÝÀÀ
acute phase serum
±Þ¼º±âÇ÷û
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
randomized clinical trial
¹«ÀÛÀ§ÀÓ»ó½ÇÇè
DSM-III
Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 3ÆÇ
DSM-III-R
Á¤½ÅÀå¾Ö(º´)Áø´ÜÅë°èÆí¶÷ Á¦ 3ÆÇ °³Á¤ÆÇ
Sudan III
¼ö´Ü III
antithrombin III
Çׯ®·Òºó III
apolipoprotein C-III
¾ÆÆ÷Áö´Ü¹é C-III
arsenazo III dye
¾Æ¸£¼¼³ªÁ¶<ºñ¼Ò¾ÆÁ¶> III ¿°·á
group III fiber
Á¦¥²¤Çí·A.
group III fiber
Á¦¥²±º¼¶À¯(ÏØàéë«).
hyperlipoproteinemia type III
°íÁö´Ü¹éÇ÷Áõ III
hyperproteinemia type III
´Ü¹é°úÀ×Ç÷(Áõ) III Çü
hypersensitivity reactions,type iii(imune complex-mediated)
IIIÇü
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
procollagen III peptide
ÇÁ·ÎÄݶó°Õ III ÆéƼµå
pseudounipolar(bipolar III) disorder
°¡¼º ´Ü±Ø¼º(¾ç±Ø¼º III)Àå¾Ö(º´).
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
clinical trial
ÀÓ»ó½ÃÇè.
clinical trial
ÀÓ»ó½ÃÇè
randomized clinical trial
¹«ÀÛÀ§ÀÓ»ó½ÇÇè
therapeutic trial
½ÃÇèÀû Ä¡·á(ãËúÐîÜö½èþ).
therapeutic trial(s)
Ä¡·áÀû ½Ãµµ(~ãËÓñ).
trial and error
½ÃÇàÂø¿À(ãËú¼ó¹è¦)
trial and error
½ÃÇàÂø¿À(ãËú¼ó¹è¦).
trial frame
°Ë»ç¾È°æ(äÑÌð)Å×
trial lens
°Ë¾È·»Áî
trial of labor
ºÐ¸¸½Ãµµ, ½ÃµµºÐ¸¸.
trial-and-error learning
½ÃÇàÂø¿ÀÇнÀ(ãËú¼ó¹è¦æßã§).
antithrombin III
Çׯ®·Òºó III
apolipoprotein C-III
¾ÆÆ÷Áö´Ü¹é C-III
arsenazo III dye
¾Æ¸£¼¼³ªÁ¶<ºñ¼Ò¾ÆÁ¶> III ¿°·á
group III fiber
Á¦¥²±º¼¶À¯(ÏØàéë«).
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½